ImmuONE
PrivateLast Round
Seed
Mar 13, 2025
Total Funding Raised
$3.15M
Momentum Score
25 /100
Company Overview
ImmuONE is a biotechnology company that provides innovative respiratory in vitro cell culture products and contract research services for inhalation safety testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Compliance & Risk
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuONE Comps
Public and private peers based on sector, stage, and business model.
ImmuONE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 13, 2025 | ||||
| Seed | Oct 26, 2023 |
Key People
Founding team and executive leadership
ImmuONE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Group | Seed |
| Mercia Ventures | Seed |
| Mercia Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors increased 174% MoM, reaching 2K.
- Apr 16, 2026
Monthly visitors increased 43% MoM.
ImmuONE Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmuONE's valuation, stock price, and market status.
